PathoQuest Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Employees
-
59
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$72M
PathoQuest General Information
Description
Developer of a molecular diagnostics technology designed to improve pathogen detection in biological samples. The company's technology combines sample preparation technology and cloud-based bioinformatics, which applies to several types of samples with a proprietary pathogen genome sequence database and automated analysis pipeline, enabling doctors to improve the breadth of pathogen detection.
Contact Information
Website
www.pathoquest.com(Operating Subsidiary)
Corporate Office
- BioPark - Bâtiment B
- 11 rue Watt
- 75013 Paris
- France
Corporate Office
- BioPark - Bâtiment B
- 11 rue Watt
- 75013 Paris
- France
PathoQuest Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Merger/Acquisition | 17-Apr-2026 | $72M | Completed | Generating Revenue | ||
| 9. Later Stage VC | 04-Apr-2023 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series B) | 09-Nov-2021 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 29-Dec-2020 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series A) | 05-Sep-2019 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A) | 14-Jun-2018 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 01-Jan-2018 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 15-Jun-2017 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 01-Jul-2013 | $5.01M | $7.76M | Completed | Startup | |
| 1. Early Stage VC | 11-Mar-2011 | $2.75M | $2.75M | Completed | Startup |
PathoQuest Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| ADP 3 | ||||||||
| ADP 3 | ||||||||
| ADP 3 | ||||||||
| P3 Shares | ||||||||
| P3 Shares | ||||||||
| P2 Shares | ||||||||
| P2 Shares | ||||||||
| P2 Shares | ||||||||
| P Shares | 57,972 | $1.073844 | $75.17 | $75.17 | 1x | $75.17 | 7.04% | |
| Ordinary | 14,424 | $1.073844 | $75.21 | $75.21 | 1x | $75.21 | 1.75% |
PathoQuest Comparisons
Industry
Financing
Details
PathoQuest Competitors (7)
One of PathoQuest’s 7 competitors is Enterome, a Venture Capital-Backed company based in Paris, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Enterome | Venture Capital-Backed | Paris, France | ||||
| PEP-Therapy | Venture Capital-Backed | Evry Cedex, France | ||||
| Karius | Venture Capital-Backed | Redwood City, CA | ||||
| Eligo Bioscience | Venture Capital-Backed | Paris, France | ||||
| Metafora | Venture Capital-Backed | Paris, France |
PathoQuest Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
PathoQuest Patents
PathoQuest Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2019289911-A1 | Method for discriminating between live and dead microbes in a sample | Active | 20-Jun-2018 | ||
| AU-2019289911-B2 | Method for discriminating between live and dead microbes in a sample | Active | 20-Jun-2018 | ||
| CA-3104220-A1 | Method for discriminating between live and dead microbes in a sample | Pending | 20-Jun-2018 | ||
| EP-3768866-A1 | Method for discriminating between live and dead microbes in a sample | Active | 20-Jun-2018 | ||
| EP-3768866-B1 | Method for discriminating between live and dead microbes in a sample | Active | 20-Jun-2018 | C12Q1/70 |
PathoQuest Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
PathoQuest Former Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aurinvest | Venture Capital | Minority | ||
| Eurazeo | Asset Manager | Minority | ||
| Idinvest Partners | PE/Buyout | Minority | ||
| Kurma Partners | Venture Capital | Minority | ||
| Norgine | PE-Backed Company | Minority |
PathoQuest FAQs
-
When was PathoQuest founded?
PathoQuest was founded in 2010.
-
Where is PathoQuest headquartered?
PathoQuest is headquartered in Paris, France.
-
What is the size of PathoQuest?
PathoQuest has 59 total employees.
-
What industry is PathoQuest in?
PathoQuest’s primary industry is Biotechnology.
-
Is PathoQuest a private or public company?
PathoQuest is a Private company.
-
What is the current valuation of PathoQuest?
The current valuation of PathoQuest is .
-
What is PathoQuest’s current revenue?
The current revenue for PathoQuest is .
-
How much funding has PathoQuest raised over time?
PathoQuest has raised $49.8M.
-
Who are PathoQuest’s investors?
Aurinvest, Eurazeo, Idinvest Partners, Kurma Partners, and Norgine are 5 of 8 investors who have invested in PathoQuest.
-
Who are PathoQuest’s competitors?
Enterome, PEP-Therapy, Karius, Eligo Bioscience, and Metafora are some of the 7 competitors of PathoQuest.
-
When was PathoQuest acquired?
PathoQuest was acquired on 17-Apr-2026.
-
Who acquired PathoQuest?
PathoQuest was acquired by Charles River Laboratories International.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
